Michael F. Mahoney holds over $109 million in Boston Scientific stock, a significant investment that reflects his commitment to the company. Over the past few years, his stock value has seen fluctuations typical in the medical device sector. Although his...

Michael F. Mahoney holds over $109 million in Boston Scientific stock, a significant investment that reflects his commitment to the company. Over the past few years, his stock value has seen fluctuations typical in the medical device sector. Although his wealth peaked during 2022, with stock values rising amid strong company performance, it has stabilized somewhat since then. His holdings peaked in 2023 due to a successful year for the company, resulting in substantial stock vesting. Despite market challenges, Mahoney's stake remains a large part of his financial portfolio, indicating his trust in Boston Scientific and its future growth. The value of his holdings is an important part of his overall compensation and showcases the alignment between his interests and those of shareholders. He continues to retain a substantial amount of his wealth in company shares, which speaks to his belief in Boston Scientific's ongoing mission and capabilities.